SEC Form D private-offering filing
Kaida BioPharma Inc.
A new SEC Form D private-offering notice from Fort Lauderdale, FL, a $3,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Biotechnology company developing targeted therapies for hard to treat gynecologic cancers, including a prolactin receptor antagonist for recurrent ovarian cancer
Filed 2026-01-21Filed to raise $3,000,000First money in 2023-10-24Raised so far $1,570,507HQ (as filed) Fort Lauderdale, FLSector Biotech ✓Stage (inferred) SeedCall status Late filing
Source linked the Form D on EDGAR↗Website verified kaida-biopharma.com↗Named in the filing 2 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.